List view / Grid view
31 March 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced contract wins for three further OncoADME programs to support clinical mass balance/ADME investigations in cancer patients...
31 March 2015 | By Victoria White
Syndax and Merck have entered into a clinical trial collaboration to evaluate the safety and efficacy of combining entinostat with Keytruda (pembrolizumab)...
31 March 2015 | By Victoria White
National Children's Bureau and Council for Disabled Children have published information to improve children's understanding of the NHS Constitution...
31 March 2015 | By Victoria White
Takeda and Sunovion today announced the results from 3 post-hoc analyses evaluating the efficacy and safety of lurasidone in patients with schizophrenia...
31 March 2015 | By Victoria White
Novartis has announced that the FDA has approved Jadenu tablets, a new oral formulation of Exjade® tablets, for the treatment of chronic iron overload...
31 March 2015 | By Victoria White
Biogen and AbbVie have announced that the EMA has validated the companies’ MAA for Zinbryta for the treatment of relapsing forms of MS in the EU...
31 March 2015 | By Victoria White
Amgen has announced that the FDA has accepted the sNDA of Kyprolis for the treatment of patients with relapsed multiple myeloma...
30 March 2015 | By Victoria White
BioDelivery Sciences announced that Clonidine Topical Gel did not meet statistical significance compared to placebo in the Phase 3 clinical study...
30 March 2015 | By Amphenol
Amphenol Advanced Sensors’ Kaye products is pleased to launch the new advanced validation System Kaye Validator AVS at Interphex Show, 21-23 April, New York...
30 March 2015 | By Victoria White
New data show that the intravitreal injection regimens associated with treating retinal disease can have a detrimental effect on patient quality of life....
30 March 2015 | By kdm communications
Tecan’s Infinite® M200 PRO reader has helped Californian company Sevident to establish rapid, sensitive immunofluorescence and colorimetric assays based on its proprietary NETs technology...
UCB has announced that its joint bid with five other UK-based organisations has been selected as a recipient of the Government’s 2014 Advanced Manufacturing Supply Chain Initiative (AMSCI), which will result in a £6.2 million grant to support the development of novel biologic treatments.
30 March 2015 | By Victoria White
Stallergenes has announced that its partner, Shionogi & Co., Ltd has received the approval of STG320 from the Japanese health authorities...
30 March 2015 | By Victoria White
BI and Lilly announce they have received a positive opinion from CHMP, recommending empagliflozin/metformin hydrochloride for the treatment type 2 diabetes...
27 March 2015 | By Victoria White
LEO Pharma has announced it submitted a MAA to 30 European Health Authorities for Enstilar cutaneous foam for the treatment of psoriasis vulgaris...
